Medical Condition News

RSS

African-American’s who adapt to mainstream American culture have risk of type 2 diabetes

Trying to find a produce store or a large grocer in an economically depressed neighborhood is about as easy as finding an apple in a candy store.

27 Aug 2013

UAB study points to protein pathway that could lead to new treatments for diabetes

The same protein tells beta cells in the pancreas to stop making insulin and then to self-destruct as diabetes worsens, according to a University of Alabama at Birmingham study published online today in the journal Nature Medicine.

27 Aug 2013

Thyroid ultrasound imaging may identify patients with low risk of cancer, can help postpone biopsy

Thyroid ultrasound imaging could be used to identify patients who have a low risk of cancer for whom biopsy could be postponed, according to a study by Rebecca Smith-Bindman, M.D., of the University of California, San Francisco, and colleagues.

27 Aug 2013

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.

27 Aug 2013

New bioinformatics software tool to identify genetic mutations responsible for cancers

Researchers at the Medical College of Wisconsin (MCW) have developed a new bioinformatics software tool designed to more easily identify genetic mutations responsible for cancers. The tool, called DrGaP, is the subject of a new paper published in the American Journal of Human Genetics.

27 Aug 2013

Study: Structural defect in skin cells can contribute to allergy development

In a new study published in Nature Genetics, Northwestern Medicine and Tel Aviv University scientists have found that a structural defect in skin cells can contribute to allergy development, including skin and food allergies, traditionally thought primarily to be a dysfunction of the immune system.

27 Aug 2013

Researchers make significant step in understanding and imaging protein synthesis

Researchers at Columbia University, in collaboration with biologists in Baylor College of Medicine, have made a significant step in understanding and imaging protein synthesis, pinpointing exactly where and when cells produce new proteins.

26 Aug 2013

Laureate Biopharma collaborates with Dyax to develop new treatment candidate for HAE

Laureate Biopharma is pleased to announce its successful collaboration with Dyax Corp. for process development and cGMP production of a new treatment candidate for hereditary angioedema.

26 Aug 2013

Two Genomic Pathways Tagged For Roles In Schizophrenia

...

26 Aug 2013

BSCs may offer new approach for reducing post-stroke cognitive dysfunction

Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored. A new study in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells reduces cognitive deficits produced by temporary occlusion of cerebral blood vessels in a rat model of stroke, suggesting that BSCs may offer a new approach for reducing post-stroke cognitive dysfunction.

26 Aug 2013

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.

26 Aug 2013

Immune Pharmaceuticals announces completion of merger with EpiCept Corporation

Immune Pharmaceuticals Inc. announced today the completion of the merger of Immune Pharmaceuticals Ltd. and EpiCept Corporation.

26 Aug 2013

Scientists receive NIH grant to study commercially-available drug for treatment of PMS

Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received a grant from the National Institutes of Health (NIH) to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for a subtype of autism called Phelan McDermid Syndrome (PMS).

26 Aug 2013

The way gut "tastes" sweet food may be defective in sufferers of type 2 diabetes

Researchers at the University of Adelaide have discovered that the way the gut "tastes" sweet food may be defective in sufferers of type 2 diabetes, leading to problems with glucose uptake.

26 Aug 2013

Screening strategy for ovarian cancer appears to be highly specific for detecting disease at early stages

A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.

26 Aug 2013

Scientists identify specific type of receptor that may aid in treatment of AD, Parkinson’s disease

Scientists at Washington University School of Medicine in St. Louis have found a way that corrupted, disease-causing proteins spread in the brain, potentially contributing to Alzheimer's disease, Parkinson's disease and other brain-damaging disorders.

26 Aug 2013

Researchers review limited literature available on PTSD prevention

Current research indicates that at some point in their life up to 84% of people will be exposed to some form of traumatic event. Although effective post-traumatic stress disorder treatments have been - and continue to be - developed, there remains a lack in relevant research pertaining to the prevention of PTSD.

26 Aug 2013

Post-doctoral fellow receives grant from NIH to study the response levels to FES in stroke patients

Rakesh Pilkar, Ph.D., a post-doctoral fellow in Human Performance and Engineering Research at Kessler Foundation, was awarded a R03, $153,000 grant by the National Institutes of Health to study the response levels to function electrical stimulation (FES) interventions in the rehabilitation of stroke patients-titled, "Identification of Responders to the FES Interventions in Stroke Populations".

26 Aug 2013

Study reports racial, ethnic differences in incidence of soft tissue sarcomas in young adults, adolescents

Mei-Chin Hsieh, MSPH, CTR, of LSU Health Sciences Center New Orleans School of Public Health's Louisiana Tumor Registry, is the lead author of a study that reports racial and ethnic differences in the incidence of soft tissue sarcomas in adolescents and young adults.

26 Aug 2013

Researchers discover additional cystic fibrosis-causing mutations

Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis, it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.

26 Aug 2013

Medical Condition News

African-American’s who adapt to mainstream American culture have risk of type 2 diabetes

UAB study points to protein pathway that could lead to new treatments for diabetes

Thyroid ultrasound imaging may identify patients with low risk of cancer, can help postpone biopsy

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

New bioinformatics software tool to identify genetic mutations responsible for cancers

Study: Structural defect in skin cells can contribute to allergy development

Researchers make significant step in understanding and imaging protein synthesis

Laureate Biopharma collaborates with Dyax to develop new treatment candidate for HAE

Two Genomic Pathways Tagged For Roles In Schizophrenia

BSCs may offer new approach for reducing post-stroke cognitive dysfunction

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Immune Pharmaceuticals announces completion of merger with EpiCept Corporation

Scientists receive NIH grant to study commercially-available drug for treatment of PMS

The way gut "tastes" sweet food may be defective in sufferers of type 2 diabetes

Screening strategy for ovarian cancer appears to be highly specific for detecting disease at early stages

Scientists identify specific type of receptor that may aid in treatment of AD, Parkinson’s disease

Researchers review limited literature available on PTSD prevention

Post-doctoral fellow receives grant from NIH to study the response levels to FES in stroke patients

Study reports racial, ethnic differences in incidence of soft tissue sarcomas in young adults, adolescents

Researchers discover additional cystic fibrosis-causing mutations

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News